富祥藥業(300497.SZ):競得景德鎮高新區(景德鎮電廠南側)地塊使用權
格隆匯 7 月 26日丨富祥藥業(300497.SZ)公佈,公司於2020年3月29日召開第三屆董事會第十次會議,審議通過了《關於與景德鎮市人民政府簽訂戰略合作協議書的議案》,同意公司設立全資子公司景德鎮富祥生命科技有限公司(“景德鎮富祥”),通過競拍等合法方式參與競買位於江西省景德鎮高新區(景德鎮電廠南側)相關地塊的土地使用權。此次競買土地事宜不構成關聯交易,不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。
景德鎮富祥近期參與了位於江西省景德鎮高新區(景德鎮電廠南側)地塊使用權的競拍,競得該地塊土地使用權,已取得《國有建設用地使用權成交確認書》,近日將與江西省景德鎮市自然資源局簽訂《國有建設用地使用權出讓合同》。
此次參與競買上述土地使用權,是為景德鎮富祥建設富祥生物醫藥項目提供必要的土地資源,有利於公司充分發揮現有產業技術優勢和產業集聚效應,推進產業鏈的延伸和優化,實現新舊動能轉換和企業的高質量發展。公司將繼續加快項目建設,積極響應和滿足市場需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.